| 25 May 2026 |
Nitroethane CAS 79-24-3 |
5.7 |
10g |
10.1g |
+0.8% |
97.81% |
Lab A |
| 25 May 2026 |
YK11 |
6.1 |
25mg |
24.0mg |
-3.8% |
95.04% |
Lab F |
| 24 May 2026 |
4-Anilinopiperidine CAS 99918-43-1 |
6.9 |
1g |
1.2g |
+15.1% |
96.70% |
Lab E |
| 24 May 2026 |
Cagrilintide 5mg + Semaglutide 5mg Blend |
6.9 |
5mg |
5.1mg |
+2.5% |
97.88% |
Lab G |
| 24 May 2026 |
Dianabol Raw |
7.4 |
10g |
12.5g |
+24.5% |
96.51% |
Lab C |
| 24 May 2026 |
Equipoise (Boldenone Undecylenate) |
7.9 |
200mg/ml |
181.6mg/ml |
-9.2% |
98.63% |
Lab C |
| 24 May 2026 |
AA Water |
5.2 |
5mg |
5.6mg |
+11.7% |
97.80% |
Lab G |
| 24 May 2026 |
BPC157 5mg + TB500 5mg Blend |
5.1 |
2mg |
2.4mg |
+20.9% |
97.93% |
Lab E |
| 24 May 2026 |
Tesofensine |
8.0 |
20mg |
19.9mg |
-0.5% |
99.93% |
Lab E |
| 24 May 2026 |
Test Propionate |
9.2 |
100mg/ml |
107.5mg/ml |
+7.5% |
99.10% |
Lab E |
| 24 May 2026 |
LGD-4033 (Ligandrol) |
4.0 |
10mg |
9.9mg |
-0.9% |
97.09% |
Lab C |
| 24 May 2026 |
SNAP-8 |
7.6 |
15mg |
13.5mg |
-10.0% |
95.36% |
Lab C |
| 24 May 2026 |
4-Anilinopiperidine CAS 99918-43-1 |
4.3 |
5g |
6.1g |
+21.4% |
96.10% |
Lab A |
| 24 May 2026 |
CJC-1295 With DAC |
5.6 |
2mg |
1.9mg |
-5.7% |
99.50% |
Lab C |
| 24 May 2026 |
Romosozumab |
10.0 |
30mg |
35.1mg |
+17.1% |
96.39% |
Lab E |
| 24 May 2026 |
SS-31 |
5.1 |
30mg |
30.5mg |
+1.7% |
99.51% |
Lab F |
| 24 May 2026 |
SNAP-8 |
4.4 |
10mg |
12.5mg |
+24.9% |
96.73% |
Lab C |
| 24 May 2026 |
Trenbolone Enanthate |
6.7 |
100mg/ml |
115.7mg/ml |
+15.7% |
99.72% |
Lab C |
| 23 May 2026 |
Letrozole |
4.9 |
50mg |
61.1mg |
+22.2% |
96.44% |
Lab F |
| 23 May 2026 |
Ovagen |
5.3 |
5mg |
4.6mg |
-7.6% |
96.60% |
Lab C |
| 23 May 2026 |
Retatrutide 30mg Pen Kit |
6.1 |
5mg |
4.7mg |
-5.3% |
97.42% |
Lab E |
| 23 May 2026 |
5-amino-1MQ |
7.8 |
30mg |
32.1mg |
+6.9% |
98.36% |
Lab B |
| 23 May 2026 |
Hyaluronic acid |
5.7 |
50mg |
47.2mg |
-5.6% |
97.77% |
Lab G |
| 22 May 2026 |
GHK-Cu |
4.9 |
50mg |
62.4mg |
+24.8% |
99.90% |
Lab E |
| 21 May 2026 |
Tirzepatide |
5.2 |
10mg |
8.25mg |
-17.5% |
99.87% |
Lab E |
| 21 May 2026 |
Retatrutide |
4.4 |
10mg |
17.1mg |
+71.0% |
99.90% |
Lab E |
| 21 May 2026 |
GLOW GHK-CU 35mg+TB500 10mg+BPC157 5mg |
6.5 |
2mg |
2.3mg |
+14.9% |
99.91% |
Lab E |
| 21 May 2026 |
Tirzepatide |
6.0 |
10mg |
10.7mg |
+7.0% |
99.32% |
Lab E |
| 21 May 2026 |
GHK-Cu |
7.8 |
50mg |
47.2mg |
-5.6% |
99.90% |
Lab E |
| 21 May 2026 |
Hyaluronic acid |
4.7 |
50mg |
55.9mg |
+11.9% |
99.06% |
Lab E |
| 21 May 2026 |
Letrozole |
6.2 |
20mg |
19.1mg |
-4.7% |
95.22% |
Lab A |
| 20 May 2026 |
BPC157 10mg + TB500 10mg Blend |
6.6 |
50mg |
59.4mg |
+18.8% |
95.83% |
Lab B |
| 20 May 2026 |
Cagrilintide 5mg + Semaglutide 5mg Blend |
6.5 |
2mg |
2.2mg |
+12.1% |
99.93% |
Lab A |
| 19 May 2026 |
GHRP-6 Acetate |
7.5 |
15mg |
16.2mg |
+8.1% |
98.16% |
Lab B |
| 19 May 2026 |
Ovagen |
7.3 |
10mg |
12.1mg |
+20.7% |
96.89% |
Lab E |
| 19 May 2026 |
YK11 |
6.4 |
50mg |
45.0mg |
-10.0% |
95.89% |
Lab B |
| 17 May 2026 |
Dihexa |
8.2 |
100mg |
93.9mg |
-6.1% |
95.18% |
Lab G |
| 17 May 2026 |
GHRP-6 Acetate |
4.8 |
10mg |
11.6mg |
+15.6% |
97.08% |
Lab E |
| 17 May 2026 |
PEG MGF |
6.0 |
15mg |
13.6mg |
-9.6% |
96.80% |
Lab B |
| 29 Jan 2026 |
Retatrutide |
4.5 |
10mg |
6.01mg |
-39.9% |
98.72% |
Lab E |
| 29 Jan 2026 |
Retatrutide |
9.2 |
20mg |
19.1mg |
-4.5% |
99.59% |
Lab E |
| 29 Jan 2026 |
PNC 27 |
8.2 |
20mg |
24.6mg |
+22.8% |
97.24% |
Lab A |
| 26 Jan 2026 |
AA Water |
6.0 |
15mg |
18.2mg |
+21.7% |
95.13% |
Lab A |
| 26 Jan 2026 |
Cabergoline |
8.3 |
25mg |
29.0mg |
+16.0% |
97.40% |
Lab A |
| 26 Jan 2026 |
Dianabol Raw |
6.3 |
500g |
618.8g |
+23.8% |
97.63% |
Lab B |
| 26 Jan 2026 |
GLOW GHK-CU 35mg+TB500 10mg+BPC157 5mg |
7.8 |
50mg |
43.6mg |
-12.8% |
99.07% |
Lab D |
| 26 Jan 2026 |
SS-31 |
4.5 |
15mg |
14.4mg |
-3.8% |
95.52% |
Lab F |
| 19 Jan 2026 |
AA Water |
5.3 |
20mg |
17.8mg |
-11.1% |
98.47% |
Lab E |
| 19 Jan 2026 |
Equipoise (Boldenone Undecylenate) |
6.2 |
200mg/ml |
227.8mg/ml |
+13.9% |
98.96% |
Lab D |
| 9 Jan 2026 |
HCG |
6.3 |
15mg |
15.7mg |
+4.5% |
97.26% |
Lab G |
| 9 Jan 2026 |
Ovagen |
4.6 |
50mg |
54.1mg |
+8.2% |
95.73% |
Lab B |
| 9 Jan 2026 |
Selank 10mg + Semax 10mg Blend |
6.2 |
2mg |
2.3mg |
+13.3% |
99.75% |
Lab G |
| 9 Jan 2026 |
Semaglutide Raw |
4.9 |
100g |
105.9g |
+5.9% |
99.25% |
Lab G |
| 9 Jan 2026 |
Semax |
5.0 |
2mg |
1.8mg |
-11.1% |
95.91% |
Lab D |
| 7 Jan 2026 |
YK11 |
7.6 |
20mg |
24.6mg |
+23.2% |
96.03% |
Lab F |
| 6 Jan 2026 |
HCG |
7.8 |
2mg |
2.5mg |
+24.1% |
97.19% |
Lab E |
| 6 Jan 2026 |
Hyaluronic acid |
5.2 |
5mg |
5.8mg |
+16.1% |
95.74% |
Lab F |
| 6 Jan 2026 |
Trenbolone Enanthate |
7.1 |
300mg/ml |
339.1mg/ml |
+13.0% |
95.26% |
Lab A |
| 29 Dec 2025 |
BAM15 |
9.5 |
50mg |
55.6mg |
+11.3% |
96.96% |
Lab E |
| 29 Dec 2025 |
BPC157 10mg + TB500 10mg Blend |
4.7 |
2mg |
2.5mg |
+24.6% |
95.53% |
Lab E |
| 29 Dec 2025 |
Cagrilintide 5mg + Semaglutide 5mg Blend |
7.0 |
20mg |
24.0mg |
+19.8% |
98.21% |
Lab B |
| 29 Dec 2025 |
CJC-1295 With DAC |
6.6 |
15mg |
17.5mg |
+16.3% |
95.92% |
Lab B |
| 29 Dec 2025 |
Dianabol Raw |
4.3 |
10g |
9.9g |
-1.0% |
95.32% |
Lab C |
| 29 Dec 2025 |
GHRP-2 Acetate |
7.3 |
30mg |
25.7mg |
-14.4% |
97.31% |
Lab C |
| 29 Dec 2025 |
GLOW GHK-CU 35mg+TB500 10mg+BPC157 5mg |
6.1 |
30mg |
29.8mg |
-0.5% |
97.22% |
Lab D |
| 29 Dec 2025 |
Letrozole |
5.4 |
100mg |
115.0mg |
+15.0% |
99.74% |
Lab D |
| 29 Dec 2025 |
Tesofensine |
7.8 |
10mg |
11.6mg |
+15.8% |
97.83% |
Lab G |
| 29 Dec 2025 |
Test Propionate |
5.8 |
100mg/ml |
89.9mg/ml |
-10.1% |
99.68% |
Lab F |
| 12 Dec 2025 |
Selank 10mg + Semax 10mg Blend |
5.1 |
10mg |
11.0mg |
+10.1% |
97.32% |
Lab E |
| 5 Dec 2025 |
Equipoise (Boldenone Undecylenate) |
6.1 |
200mg/ml |
246.5mg/ml |
+23.2% |
99.67% |
Lab G |
| 5 Dec 2025 |
HCG |
8.5 |
2mg |
2.3mg |
+17.1% |
97.25% |
Lab C |
| 5 Dec 2025 |
Semax |
7.0 |
5mg |
6.2mg |
+23.6% |
99.85% |
Lab D |
| 23 Nov 2025 |
CJC-1295 With DAC |
4.1 |
30mg |
29.5mg |
-1.5% |
97.78% |
Lab D |
| 23 Nov 2025 |
Clenbuterol |
4.0 |
20mg |
20.3mg |
+1.3% |
95.25% |
Lab A |
| 23 Nov 2025 |
EPO |
8.1 |
50mg |
44.4mg |
-11.2% |
97.07% |
Lab C |
| 23 Nov 2025 |
Romosozumab |
6.8 |
50mg |
46.6mg |
-6.8% |
98.48% |
Lab C |
| 17 Nov 2025 |
BPC157 5mg + TB500 5mg Blend |
4.3 |
10mg |
10.6mg |
+6.3% |
97.42% |
Lab B |
| 17 Nov 2025 |
KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg |
7.5 |
50mg |
58.7mg |
+17.3% |
99.76% |
Lab C |
| 17 Nov 2025 |
LGD-4033 (Ligandrol) |
5.3 |
10mg |
11.9mg |
+18.6% |
96.42% |
Lab B |
| 17 Nov 2025 |
PNC 27 |
8.2 |
15mg |
14.7mg |
-1.8% |
95.71% |
Lab B |
| 17 Nov 2025 |
PNC 27 |
5.9 |
10mg |
9.7mg |
-2.7% |
95.29% |
Lab F |
| 17 Nov 2025 |
Semax |
5.6 |
10mg |
9.1mg |
-9.4% |
99.87% |
Lab D |
| 14 Nov 2025 |
IGF-1 LR3 |
6.7 |
15mg |
13.1mg |
-12.8% |
96.16% |
Lab A |
| 14 Nov 2025 |
P21 |
5.2 |
20mg |
20.6mg |
+2.9% |
98.07% |
Lab E |
| 14 Nov 2025 |
Test Propionate |
6.9 |
300mg/ml |
337.6mg/ml |
+12.5% |
97.11% |
Lab F |
| 4 Nov 2025 |
Hyaluronic acid |
7.7 |
30mg |
35.4mg |
+17.9% |
97.14% |
Lab G |
| 4 Nov 2025 |
KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg |
9.0 |
2mg |
2.0mg |
-2.3% |
97.79% |
Lab C |
| 4 Nov 2025 |
P21 |
7.5 |
50mg |
55.9mg |
+11.9% |
95.16% |
Lab A |
| 4 Nov 2025 |
Selank 10mg + Semax 10mg Blend |
5.8 |
15mg |
17.4mg |
+15.7% |
96.24% |
Lab E |
| 4 Nov 2025 |
SS-31 |
5.7 |
2mg |
2.4mg |
+19.8% |
98.84% |
Lab A |
| 4 Nov 2025 |
Tesofensine |
9.5 |
100mg |
86.9mg |
-13.1% |
99.35% |
Lab D |
| 4 Nov 2025 |
Trenbolone Enanthate |
4.0 |
200mg/ml |
188.2mg/ml |
-5.9% |
98.05% |
Lab F |
| 17 Oct 2025 |
EPO |
8.8 |
20mg |
18.9mg |
-5.4% |
95.79% |
Lab D |
| 17 Oct 2025 |
Romosozumab |
9.0 |
50mg |
60.7mg |
+21.3% |
98.23% |
Lab G |
| 17 Oct 2025 |
Semax |
6.0 |
15mg |
13.6mg |
-9.1% |
98.35% |
Lab C |
| 17 Oct 2025 |
Test Propionate |
8.4 |
300mg/ml |
320.0mg/ml |
+6.7% |
97.95% |
Lab G |
| 9 Oct 2025 |
BPC157 10mg + TB500 10mg Blend |
5.8 |
50mg |
54.5mg |
+8.9% |
97.31% |
Lab F |
| 9 Oct 2025 |
IGF-1 LR3 |
6.9 |
30mg |
31.1mg |
+3.7% |
95.82% |
Lab A |
| 9 Oct 2025 |
Letrozole |
5.0 |
50mg |
42.8mg |
-14.5% |
99.73% |
Lab A |
| 9 Oct 2025 |
SS-31 |
5.1 |
20mg |
23.3mg |
+16.5% |
99.94% |
Lab B |
| 9 Oct 2025 |
Trenbolone Enanthate |
7.0 |
300mg/ml |
278.6mg/ml |
-7.1% |
95.36% |
Lab C |
| 3 Oct 2025 |
BPC157 10mg + TB500 10mg Blend |
6.0 |
15mg |
13.0mg |
-13.6% |
96.47% |
Lab A |
| 3 Oct 2025 |
EPO |
10.0 |
10mg |
10.6mg |
+6.4% |
96.46% |
Lab E |
| 3 Oct 2025 |
GHRP-6 Acetate |
8.4 |
10mg |
11.1mg |
+11.2% |
98.30% |
Lab B |
| 3 Oct 2025 |
GHRP-6 Acetate |
9.0 |
15mg |
13.7mg |
-8.6% |
96.03% |
Lab A |